These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1212 related articles for article (PubMed ID: 7114305)

  • 21. [Clinical heterogeneity of dementia of the Alzheimer type].
    Gavrilova SI; Korsakova NK; Vavilov SB; Selezneva ND; Kalyn IaB; Dybovskaia NR; Roshchina IF; Medvedev LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(9):44-50. PubMed ID: 2176041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia.
    Csernansky JG; Dong H; Fagan AM; Wang L; Xiong C; Holtzman DM; Morris JC
    Am J Psychiatry; 2006 Dec; 163(12):2164-9. PubMed ID: 17151169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progression of illness in the differential diagnosis of primary dementia.
    Zubenko GS
    Am J Psychiatry; 1990 Apr; 147(4):435-8. PubMed ID: 2316730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A simple, reliable clinical behavioral scale for assessing demented patients.
    Haycox JA
    J Clin Psychiatry; 1984 Jan; 45(1):23-4. PubMed ID: 6693359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Empirical evaluation of the global deterioration scale for staging Alzheimer's disease.
    Reisberg H; Ferris SH; Sclan SG
    Am J Psychiatry; 1993 Apr; 150(4):680-2. PubMed ID: 8465902
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mild cognitive impairment: a prodromal phase of dementia?].
    Jonker C; Comijs HC
    Tijdschr Gerontol Geriatr; 2007 Jul; 38(3):115-21. PubMed ID: 17642317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new rating scale for Alzheimer's disease.
    Rosen WG; Mohs RC; Davis KL
    Am J Psychiatry; 1984 Nov; 141(11):1356-64. PubMed ID: 6496779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differing patterns of psychiatric impairment in Alzheimer and demented parkinsonian patients.
    Soliveri P; Zappacosta MB; Austoni L; Caffarra P; Scaglioni A; Testa D; Palazzini E; Caraceni T; Girotti F
    Ital J Neurol Sci; 1994 Nov; 15(8):407-11. PubMed ID: 7875958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bedside differentiation of depressive pseudodementia from dementia.
    Reynolds CF; Hoch CC; Kupfer DJ; Buysse DJ; Houck PR; Stack JA; Campbell DW
    Am J Psychiatry; 1988 Sep; 145(9):1099-103. PubMed ID: 3414853
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Frequency and presentation of depressive symptoms in patients with primary degenerative dementia.
    Lazarus LW; Newton N; Cohler B; Lesser J; Schweon C
    Am J Psychiatry; 1987 Jan; 144(1):41-5. PubMed ID: 3799838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the clock drawing test appropriate for screening for mild cognitive impairment?--Results of the German study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe).
    Ehreke L; Luppa M; Luck T; Wiese B; Weyerer S; Eifflaender-Gorfer S; Weeg D; Olbrich J; van den Bussche H; Bachmann C; Eisele M; Maier W; Jessen F; Wagner M; Fuchs A; Pentzek M; Angermeyer MC; König HH; Riedel-Heller SG;
    Dement Geriatr Cogn Disord; 2009; 28(4):365-72. PubMed ID: 19887799
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mysterious cognitive disorder of Parkinson disease.
    Mortimer JA
    Alzheimer Dis Assoc Disord; 1990; 4(3):129-32. PubMed ID: 2223019
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
    Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
    Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer disease.
    Schmeidler J; Mohs RC; Aryan M
    Alzheimer Dis Assoc Disord; 1998 Sep; 12(3):146-51. PubMed ID: 9772016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rate of cognitive change measured by neuropsychologic test performance in 3 distinct dementia syndromes.
    Wicklund AH; Rademaker A; Johnson N; Weitner BB; Weintraub S
    Alzheimer Dis Assoc Disord; 2007; 21(4):S70-8. PubMed ID: 18090428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinical utility of the Mattis Dementia Rating Scale in assessing cognitive decline in Alzheimer's disease.
    Miller JM; Pliskin NH
    Int J Neurosci; 2006 May; 116(5):613-27. PubMed ID: 16644521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Age- and education-specific reference values for the cognitive test of the SIDAM (Structured interview for the diagnosis of dementia of the Alzheimer type, multi-infarct dementia and dementias of other etiology according to ICD-10 and DSM-IV)].
    Busse A; Aurich C; Zaudig M; Riedel-Heller S; Matschinger H; Angermeyer MC
    Z Gerontol Geriatr; 2002 Dec; 35(6):565-74. PubMed ID: 12491003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability of psychiatric scales in patients with dementia of the Alzheimer type.
    Gottlieb GL; Gur RE; Gur RC
    Am J Psychiatry; 1988 Jul; 145(7):857-60. PubMed ID: 3381932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of P300 and a dementia rating scale in the evaluation of cognitive dysfunction in MS.
    Tourtellotte WW; Syndulko K; Jennings P
    Acta Neurol Scand Suppl; 1984; 101():32-4. PubMed ID: 6594913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 61.